Aplastic anemia is not a type of cancer, but it can increase the risk of developing leukemia. Aplastic anemia occurs when the bone marrow no longer produces blood cells. Anything that damages stem ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

Please provide your email address to receive an email when new articles are posted on . Outcomes after haploidentical transplant for severe aplastic anemia have improved significantly with use of post ...

Baltimore-based Johns Hopkins Kimmel Cancer Center physicians successfully treated 16 patients with aplastic anemia, a rare and deadly form of bone marrow failure, and published their findings in ...

Aplastic anaemia is a rare, life‐threatening disorder of the bone marrow characterised by pancytopenia and a hypocellular marrow. The primary pathophysiology involves immune-mediated destruction of ...

Medically reviewed by Gagandeep Brar, MD Key Takeaways Bone marrow fills the cavities in your bones and produces blood ...

What Is Omisirge, and Why Does It Matter? Omisirge (omidubicel-onlv) is a type of cell therapy made from umbilical cord blood. It helps your body make new blood cells after a stem cell transplant.

Study findings showed 86% of patients had early and sustained neutrophil recovery at 100 days. The Food and Drug Administration (FDA) has approved Omisirge ® (omidubicel-onlv) for adults and pediatric ...

Tia Szczepanski, 29, is a pediatric nurse in the ICU at Albany Medical Center and has not been able to go to work recently. That’s because she has been diagnosed with severe aplastic anemia and now ...

A Prescription Drug User Fee Act target date of December 10, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...